logo

For the Inventor, By the Inventor

Arlington, MA, United States of America

Paul D Lyne

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biogen Idec Ma Inc., Astrazeneca Ab, Biogen Ma Inc.. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul D Lyne. Retrieved from https://idiyas.com/inventor/paul-d-lyne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 27.3



Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Allston, MA (US) (2008)
  • Waltham, MA (US) (2008 - 2014)
  • Arlington, MA (US) (2008 - 2019)

Company Filing History:

goldMedal6 out of 216 
 
Biogen Idec Ma Inc.
 patents
silverMedal3 out of 1,534 
 
Astrazeneca Ab
 patents
bronzeMedal2 out of 269 
 
Biogen Ma Inc.
 patents

Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 10336826 - Antibodies to VLA-1 (2019-07-02),
2. 9644030 - Antibodies to VLA-1 (2017-05-09),
3. 8835465 - Pyrazolylaminopyridine derivatives useful as kinase inhibitors (2014-09-16),
4. 8324252 - Pyrazolylaminopyridine derivatives useful as kinase inhibitors (2012-12-04),
5. 8084028 - Antibodies to VLA-1 (2011-12-27),
6. 7910099 - Antibodies to VLA-1 (2011-03-22),
7. 7723073 - Antibodies to VLA-1 (2010-05-25),
8. 7691865 - Pyrazolopyridines and methods of making and using the same (2010-04-06),
9. 7429644 - Humanized anti-LT-β-R antibodies (2008-09-30),
10. 7423061 - Substitute thiophenes and uses thereof (2008-09-09),
11. 7358054 - Antibodies to VLA-1 (2008-04-15),

Title: The Innovations of Paul D. Lyne

Introduction

Paul D. Lyne is a notable inventor based in Arlington, MA, with a significant contribution to the field of immunology. He holds a total of 11 patents, showcasing his dedication to advancing medical science and treatment options.

Latest Patents

Among his latest patents are innovative antibodies that specifically bind to VLA-1 integrin. These antibodies are designed to treat immunological disorders in subjects. His work also includes the crystal structures of complexes formed by VLA-1 antibodies and their ligands. Additionally, he has identified VLA-1 antagonists and agonists using the structure coordinates of these complexes.

Career Highlights

Throughout his career, Paul has worked with prominent companies such as Biogen Idec MA Inc. and AstraZeneca AB. His experience in these organizations has allowed him to contribute significantly to the development of therapeutic solutions.

Collaborations

Paul has collaborated with esteemed colleagues, including Jose William Saldanha and Michael Karpusas. These partnerships have further enriched his research and innovation efforts.

Conclusion

Paul D. Lyne's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…